PubMed HealthSearch

PubMed · 8718332

Experimental designs.

Abstract

This article discusses randomized clinical trials, double blind designs and factorial designs and describes and explains their main requirements. It is shown that the randomized clinical trial is not a different experimental design, but is one that reflects the purpose for and the scale on which the post-test only or pre-test/post-test designs are often used. A common method for the prevention of experimenter bias in clinical trials is the double blind trial. Factorial designs make the simultaneous manipulation of two or more independent variables possible, thus producing data about their effect on the development variable.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Behi, M Nolan. Experimental designs.. https://doi.org/10.12968/bjon.1996.5.12.754

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.

Our objective was to determine changes in surface tension of tracheal aspirate over the first 4-5 days of life in babies with hyaline membrane disease, with and without synthetic surfactant replacement. Tracheal aspirates were collected prior to and for 96-108 hr after initiation of a randomized double-blind trial of synthetic surfactant (EXOSURF Neonatal) or air-treated control patients. Using the captive bubble technique, we measured minimum surface tension (initial adsorption, first quasi-static compression, dynamic cycling at 30 cpm, second quasi-static compression and 5 min after quasi-static compressions) in 39 surfactant-treated and 44 control babies. We also compared minimum surface tension with the respiratory support provided. Twelve hours after one dose of synthetic surfactant, minimum surface tension on first quasistatic compression decreased significantly from 20.9+/-1.4 to 17.6+/-1.3 mN/m compared to air-treated babies, who did not show any change. Reduction in minimum tracheal aspirate surface tension on first quasi-static compression and during dynamic cycling over 48-60 hr occurred more rapidly in surfactant-treated babies. Ventilator support did not correlate with minimum tracheal aspirate surface tension. We conclude that treatment of babies with synthetic surfactant improved tracheal aspirate minimum surface tension within 12 hr of the first dose and for the next 48-60 hr.

Double-Blind Method